In vivo testing for gold nanoparticle toxicity.

Area of Science:

• Nanotechnology
• Toxicology
• Immunology
• Analytical Chemistry

Background:

• Nanomaterials offer unique properties but pose potential health risks.
• Assessing nanomaterial toxicity requires robust and sensitive methodologies.
• Existing methods may not fully capture the complex interactions of nanomaterials within biological systems.

Purpose of the Study:

• To describe a comprehensive technique for measuring nanomaterial toxicity in a murine model.
• To evaluate the nanotoxicity and immunological response to nanomaterials.
• To determine the target organ specificity of nanomaterials.

Main Methods:

• Submandibular bleeding and urine collection on cellophane sheets for biosample acquisition.
• Inductively coupled plasma optical emission spectroscopy (ICP-OES) for nanotoxicity analysis of blood, urine, and digested organs.
• Coulter counter for assessing immunological response in blood samples.
• Analysis of major organs for filtration and nanomaterial distribution.

Main Results:

• The described technique successfully quantified nanotoxicity in biosamples.
• Immunological responses were effectively measured using a standard Coulter counter.
• ICP-OES analysis of organs provided insights into nanomaterial target specificity.
• The method was validated by assessing the nanotoxicity of a modified tiopronin monolayer-protected cluster.

Conclusions:

• A reliable murine model technique for comprehensive nanomaterial toxicity assessment has been established.
• The integrated approach allows for evaluation of nanotoxicity, immunological effects, and biodistribution.
• This method provides valuable data for understanding nanomaterial safety and targeted delivery.